• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Usefulness of antithrombin III and alpha 2-plasmin inhibitor in early differentiation of fulminant hepatitis and severe form of acute hepatitis.

作者信息

Sato S, Murakami A, Yoshida T, Kashiwabara T, Suzuki K, Kaito I

出版信息

Gastroenterol Jpn. 1983 Apr;18(2):128-36. doi: 10.1007/BF02774687.

DOI:10.1007/BF02774687
PMID:6852439
Abstract

To evaluate the usefulness of antithrombin III (AT III) and alpha 2-plasmin inhibitor (alpha 2PI) in early differential diagnosis of fulminant hepatitis from the severe form of acute hepatitis, the activities of AT III and alpha 2PI were measured in plasma of 15 patients with fulminant hepatitis and 6 patients with severe form of acute hepatitis. The activities of prothrombin time (PT), hepaplastintest (HPT) and thrombotest (TT) were also evaluated. The mean values and the standard errors (SE) for PT, HPT and TT were 21.1 +/- 2.6%, 14.0 +/- 1.6% and 10.3 +/- 1.7%, respectively, in the early stage of fulminant hepatitis and 25.3 +/- 2.4%, 21.6 +/- 4.6% and 15.8 +/- 3.6%, respectively, in the severe form of acute hepatitis. No significant difference in the tests between these two diseases was noted. On the other hand, the mean values +/- SE for AT III and alpha 2PI were 13.7 +/- 4.6% and 25.6 +/- 8.6% in fulminant hepatitis and 70.2 +/- 28.5% and 98.7 +/- 9.7% in the severe form of acute hepatitis. A significant difference between the two diseases was observed. From the above, it is concluded that measuring AT III and alpha 2PI along with PT, HPT and TT is useful for early diagnosis of fulminant hepatitis.

摘要

相似文献

1
Usefulness of antithrombin III and alpha 2-plasmin inhibitor in early differentiation of fulminant hepatitis and severe form of acute hepatitis.
Gastroenterol Jpn. 1983 Apr;18(2):128-36. doi: 10.1007/BF02774687.
2
[Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].[弥散性血管内凝血患者血浆抗凝血酶III和α2纤溶酶抑制物活性测定的临床相关性——分子标志物在弥散性血管内凝血病理生理学分析中的应用]
Rinsho Byori. 1994 Jan;42(1):45-55.
3
The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.败血症、暴发性肝衰竭和心源性休克中的蛋白酶抑制剂复合物(抗凝血酶III-凝血酶、α2抗纤溶酶-纤溶酶和α1抗胰蛋白酶-弹性蛋白酶):对DIC/F综合征诊断和治疗控制的价值
Behring Inst Mitt. 1986 Feb(79):87-103.
4
Importance of measuring plasma thrombin-antithrombin III complex levels when using antithrombin III concentrate therapy in fulminant hepatic failure.在暴发性肝衰竭患者使用抗凝血酶III浓缩物治疗时,测定血浆凝血酶 - 抗凝血酶III复合物水平的重要性。
Scand J Gastroenterol. 1991 Nov;26(11):1188-92. doi: 10.3109/00365529108998612.
5
Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.供体血液及血浆成分中的抗凝血酶III、纤溶酶原、纤溶酶和α-2-抗纤溶酶。
Ann Clin Lab Sci. 1985 Mar-Apr;15(2):165-70.
6
Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.黄疸患者的抗凝血酶III、纤溶酶原和α2抗纤溶酶。临床应用及预后意义。
Gut. 1984 Oct;25(10):1050-6. doi: 10.1136/gut.25.10.1050.
7
[Correlation between coagulation and fibrinolysis in patient with cerebrovascular accident at acute stage].
No To Shinkei. 1982 Oct;34(10):1007-10.
8
Plasma antithrombin III, alpha 2-plasmin inhibitor and plasminogen activities in cases of various liver diseases.各种肝病患者血浆抗凝血酶III、α2-纤溶酶抑制剂及纤溶酶原活性
Tokai J Exp Clin Med. 1986 Nov;11(5):345-52.
9
Fibrinolytic abnormalities following liver transplantation in patients with fulminant hepatic failure.暴发性肝衰竭患者肝移植后的纤溶异常。
Eur J Gastroenterol Hepatol. 1995 Feb;7(2):155-9.
10
Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation.
Am J Hematol. 1988 Jul;28(3):162-6. doi: 10.1002/ajh.2830280306.

引用本文的文献

1
Serum hyaluronate in patients with acute and fulminant hepatitis.
J Gastroenterol. 1996 Apr;31(2):237-41. doi: 10.1007/BF02389523.

本文引用的文献

1
Thrombotest. A new method for controlling anticoagulant therapy.凝血试验。一种控制抗凝治疗的新方法。
Lancet. 1959 Nov 7;2(7106):754-8. doi: 10.1016/s0140-6736(59)90857-8.
2
[Rapid physiological coagulation method in determination of fibrinogen].[快速生理凝血法测定纤维蛋白原]
Acta Haematol. 1957 Apr;17(4):237-46. doi: 10.1159/000205234.
3
The fibrin plate method for estimating fibrinolytic activity.用于评估纤维蛋白溶解活性的纤维蛋白平板法。
Arch Biochem Biophys. 1952 Oct;40(2):346-51. doi: 10.1016/0003-9861(52)90121-5.
4
Increased plasma antithrombin III level in hyperlipidemic subjects.高脂血症患者血浆抗凝血酶III水平升高。
Clin Chim Acta. 1981 Mar 5;110(2-3):147-55. doi: 10.1016/0009-8981(81)90344-2.
5
Changes in antithrombin III activity in the various clinical forms of viral hepatitis.各种临床类型病毒性肝炎中抗凝血酶III活性的变化
Folia Med (Plovdiv). 1981;23(2):11-7.
6
Significance of intravascular coagulation and fibrinolysis in acute hepatic failure.
Gut. 1974 Feb;15(2):83-8. doi: 10.1136/gut.15.2.83.
7
Assay of alpha2-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate.利用纤溶酶特异性三肽底物测定α2-纤溶酶抑制剂活性。
Thromb Res. 1978 Jun;12(6):1147-56. doi: 10.1016/0049-3848(78)90069-5.
8
The alpha2-plasmin inhibitor levels in liver diseases.肝脏疾病中α2-纤溶酶抑制剂水平
Clin Chim Acta. 1978 Mar 1;84(1-2):99-105. doi: 10.1016/0009-8981(78)90481-3.
9
Heparin cofactor activity measured with an amidolytic method.用酰胺水解法测定肝素辅因子活性。
Thromb Res. 1975 Apr;6(4):287-94. doi: 10.1016/0049-3848(75)90078-x.